Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionMitchell Capital Management Co
Latest Disclosed Ownership10,030 shares
Latest Disclosed Value $ 9,225,068
Mitchell Capital Management Co reports 0.47% increase in ownership of LLY / Eli Lilly and Company

On May 11, 2026 - Mitchell Capital Management Co filed a 13F-HR form disclosing ownership of 10,030 shares of Eli Lilly and Company (US:LLY) valued at $9,225,293 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 9,983 shares of Eli Lilly and Company. This represents a change in shares of 0.47% during the quarter. The current value of the position is $10,820,163 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Eli Lilly COM 532457108 10,030 47 0.47 9,225 -14.01 1.6927
2026-02-10 2025-12-31 13F Eli Lilly COM 532457108 9,983 3,156 46.23 10,728 105.99 1.9179
2025-11-06 2025-09-30 13F Eli Lilly COM 532457108 6,827 -208 -2.96 5,209 -4.05 0.8917
2025-07-25 2025-06-30 13F Eli Lilly COM 532457108 7,035 -5,376 -43.32 5,429 -47.04 1.0149
2025-05-09 2025-03-31 13F Eli Lilly COM 532457108 12,411 774 6.65 10,250 14.10 1.9539
2025-02-05 2024-12-31 13F Eli Lilly COM 532457108 11,637 -266 -2.23 8,983 -14.80 1.5733
2024-11-12 2024-09-30 13F Eli Lilly COM 532457108 11,903 -523 -4.21 10,545 -6.27 1.8428
2024-08-08 2024-06-30 13F Eli Lilly COM 532457108 12,426 92 0.75 11,250 17.24 1.9809
2024-05-06 2024-03-31 13F Eli Lilly COM 532457108 12,334 -237 -1.89 9,596 30.94 1.8412
2024-02-13 2023-12-31 13F Eli Lilly COM 532457108 12,571 138 1.11 7,328 9.73 1.5430
2023-11-03 2023-09-30 13F Eli Lilly COM 532457108 12,433 -4,239 -25.43 6,678 -14.59 1.5860
2023-08-08 2023-06-30 13F Eli Lilly COM 532457108 16,672 -229 -1.35 7,819 34.72 1.7877
2023-05-08 2023-03-31 13F Eli Lilly COM 532457108 16,901 7,506 79.89 5,804 68.87 1.4397
2023-02-13 2022-12-31 13F Eli Lilly COM 532457108 9,395 -5 -0.05 3,437 13.06 0.9506
2022-10-28 2022-09-30 13F Eli Lilly COM 532457108 9,400 -22 -0.23 3,040 -0.49 0.8628
2022-07-29 2022-06-30 13F Eli Lilly COM 532457108 9,422 -28 -0.30 3,055 12.90 0.8560
2022-04-29 2022-03-31 13F Eli Lilly COM 532457108 9,450 2 0.02 2,706 3.68 0.6055
2022-01-28 2021-12-31 13F Lilly, Eli COM 532457108 9,448 -90 -0.94 2,610 18.42 0.5286
2021-11-02 2021-09-30 13F Lilly, Eli COM 532457108 9,538 -19 -0.20 2,204 0.46 0.4937
2021-08-10 2021-06-30 13F Lilly, Eli COM 532457108 9,557 -497 -4.94 2,194 16.83 0.4815
2021-04-29 2021-03-31 13F Lilly, Eli COM 532457108 10,054 -1,042 -9.39 1,878 0.27 0.4583
2021-02-08 2020-12-31 13F Lilly, Eli COM 532457108 11,096 -53 -0.48 1,873 13.52 0.4701
2020-11-10 2020-09-30 13F Lilly, Eli COM 532457108 11,149 -160 -1.41 1,650 -11.15 0.4789
2020-07-29 2020-06-30 13F Lilly, Eli COM 532457108 11,309 -50 -0.44 1,857 17.83 0.5977
2020-05-06 2020-03-31 13F Lilly, Eli COM 532457108 11,359 -330 -2.82 1,576 2.60 0.6145
2020-02-07 2019-12-31 13F Lilly, Eli COM 532457108 11,689 -711 -5.73 1,536 10.74 0.4882
2019-11-07 2019-09-30 13F Lilly, Eli COM 532457108 12,400 -123 -0.98 1,387 0.00 0.4686
2019-07-24 2019-06-30 13F Lilly, Eli COM 532457108 12,523 -872 -6.51 1,387 -20.20 0.4650
2019-05-02 2019-03-31 13F Lilly, Eli COM 532457108 13,395 265 2.02 1,738 14.42 0.6142
2019-02-08 2018-12-31 13F Lilly, Eli COM 532457108 13,130 13,130 1,519 0.6419
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.